Literature DB >> 12566892

Effects of sildenafil citrate (Viagra) on choroidal congestion.

Timothy J McCulley1, James K Luu, Michael F Marmor, William J Feuer.   

Abstract

This study evaluates the effect of sildenafil on choroidal vascular congestion and its correlation with visual effects. Thirteen healthy subjects were randomized to a sildenafil group (n = 7, 3 M, 4 F), who received 200 mg of sildenafil, and a control (n = 6, 5 F, 1 M) group, who received no drug. Measurements of choroidal thickness with ultrasonography, color vision with Desaturated Panel D-15 Test, and contrast sensitivity with CSV-1000e charts (Vector Vision) were performed at baseline and at 90 and 180 min. Mean choroidal thickness and contrast sensitivity did not change significantly relative to baseline in either group. However, the variance in differences between repeat and baseline measurements of choroidal thickness was significantly higher at 90 min (p = 0.003) in the sildenafil subjects. Color discrimination error scores increased after sildenafil but did not correlate with changes in choroidal thickness. An oral dose of 200 mg of sildenafil caused small inconsistent changes in choroidal thickness, which did not correlate with visual effects. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12566892     DOI: 10.1159/000067549

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

1.  Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra(®) ).

Authors:  David Y Kim; Ronald H Silverman; Robison Vernon Paul Chan; Aziz A Khanifar; Mark Rondeau; Harriet Lloyd; Peter Schlegel; Donald Jackson Coleman
Journal:  Acta Ophthalmol       Date:  2012-09-13       Impact factor: 3.761

2.  Viagra-associated serous macular detachment.

Authors:  Polly Quiram; Sean Dumars; Bobbie Parwar; David Sarraf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

3.  Choroidal expansion during the water drinking test.

Authors:  Carlos Gustavo Vasconcelos De Moraes; Alexandre Soares Castro Reis; Adhele Furlani de Sá Cavalcante; Milena Eimi Sano; Remo Susanna
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-06       Impact factor: 3.117

4.  Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.

Authors:  Licia Matieli; Adriana Berezovsky; Solange Rios Salomão; Norma Allemann; Elisabeth Nogueira Martins; Flavio E Hirai; Jaquelina Ota-Arakaki; Maira S A Morales; Denise de Freitas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-19       Impact factor: 3.117

5.  Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Authors:  Barbara M Wirostko; Charles Tressler; Lie-Ju Hwang; Gary Burgess; Alan M Laties
Journal:  BMJ       Date:  2012-02-21

6.  Intraocular Hemorrhage due to use of Sildenafil in a Patient with Diabetes.

Authors:  Cagri Ilhan; Mehmet Murat Uzel; Mehmet Citirik
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018

Review 7.  Visual Side Effects Linked to Sildenafil Consumption: An Update.

Authors:  Eva Ausó; Violeta Gómez-Vicente; Gema Esquiva
Journal:  Biomedicines       Date:  2021-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.